MaxCyte ExPERT GTx Electroporation Device and Installation/Operational Qualification (IQ/OQ)

The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure a MaxCyte ExPERT GTx Electroporation Device along with associated Installation and Operational Qualification (IQ/OQ) services. This procurement aims to replace the existing MaxCyte Gen2 GT model, which will no longer be supported by the manufacturer, ensuring continuity in the manufacturing of cell-based therapies under stringent cGMP regulations. The MaxCyte ExPERT GTx platform is critical for introducing genetic material into cells, supporting clinical-scale processing, and maintaining compliance with FDA standards. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov, referencing POTS: 26-003578, as this opportunity is being conducted on a sole source basis with no solicitation planned.